Cartesian Therapeutics shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Cartesian Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Cartesian Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cartesian Therapeutics by Charles Schwab Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $254k | 25k | 10.22 |
| 2025-06-30 | $259k | 25k | 10.39 |
| 2025-03-31 | $386k | 29k | 13.18 |
| 2024-12-31 | $480k | 27k | 17.91 |
| 2024-09-30 | $307k | 19k | 16.12 |
| 2024-06-30 | $515k | 19k | 27.01 |
More positions owned by Charles Schwab Investment Management
Home Depot (HD)
View all positions for Charles Schwab Investment Management